PMC:7463108 / 34550-34824 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T316","span":{"begin":18,"end":27},"obj":"Body_part"},{"id":"T317","span":{"begin":121,"end":124},"obj":"Body_part"},{"id":"T318","span":{"begin":144,"end":153},"obj":"Body_part"},{"id":"T319","span":{"begin":217,"end":220},"obj":"Body_part"},{"id":"T320","span":{"begin":236,"end":239},"obj":"Body_part"}],"attributes":[{"id":"A316","pred":"fma_id","subj":"T316","obj":"http://purl.org/sig/ont/fma/fma68923"},{"id":"A317","pred":"fma_id","subj":"T317","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A318","pred":"fma_id","subj":"T318","obj":"http://purl.org/sig/ont/fma/fma68923"},{"id":"A319","pred":"fma_id","subj":"T319","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A320","pred":"fma_id","subj":"T320","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"24 Human, primary microglia (El-Hage et al. 2014)\nHIVSF162 (R5) No • U50,488; U69,593 (KOR agonists)\n• Dynorphin Al-13 ↓ HIV p24 Human, primary microglia (Chao et al. 1996b)\n• HIVJR-FL (R5)\n• gp120 No β-endorphin • ↑ HIV expression\n• ↑ HIV p24 (14-day post infection)\n• gp12"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T91","span":{"begin":60,"end":62},"obj":"Disease"},{"id":"T92","span":{"begin":186,"end":188},"obj":"Disease"},{"id":"T93","span":{"begin":257,"end":266},"obj":"Disease"}],"attributes":[{"id":"A91","pred":"mondo_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/MONDO_0016654"},{"id":"A92","pred":"mondo_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/MONDO_0016654"},{"id":"A93","pred":"mondo_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"24 Human, primary microglia (El-Hage et al. 2014)\nHIVSF162 (R5) No • U50,488; U69,593 (KOR agonists)\n• Dynorphin Al-13 ↓ HIV p24 Human, primary microglia (Chao et al. 1996b)\n• HIVJR-FL (R5)\n• gp120 No β-endorphin • ↑ HIV expression\n• ↑ HIV p24 (14-day post infection)\n• gp12"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T412","span":{"begin":3,"end":8},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T413","span":{"begin":18,"end":27},"obj":"http://purl.obolibrary.org/obo/CL_0000129"},{"id":"T414","span":{"begin":129,"end":134},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T415","span":{"begin":144,"end":153},"obj":"http://purl.obolibrary.org/obo/CL_0000129"},{"id":"T416","span":{"begin":182,"end":184},"obj":"http://purl.obolibrary.org/obo/CLO_0003358"}],"text":"24 Human, primary microglia (El-Hage et al. 2014)\nHIVSF162 (R5) No • U50,488; U69,593 (KOR agonists)\n• Dynorphin Al-13 ↓ HIV p24 Human, primary microglia (Chao et al. 1996b)\n• HIVJR-FL (R5)\n• gp120 No β-endorphin • ↑ HIV expression\n• ↑ HIV p24 (14-day post infection)\n• gp12"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T310","span":{"begin":69,"end":76},"obj":"Chemical"},{"id":"T311","span":{"begin":91,"end":99},"obj":"Chemical"},{"id":"T312","span":{"begin":103,"end":112},"obj":"Chemical"},{"id":"T313","span":{"begin":113,"end":115},"obj":"Chemical"},{"id":"T314","span":{"begin":182,"end":184},"obj":"Chemical"}],"attributes":[{"id":"A310","pred":"chebi_id","subj":"T310","obj":"http://purl.obolibrary.org/obo/CHEBI_73358"},{"id":"A311","pred":"chebi_id","subj":"T311","obj":"http://purl.obolibrary.org/obo/CHEBI_48705"},{"id":"A312","pred":"chebi_id","subj":"T312","obj":"http://purl.obolibrary.org/obo/CHEBI_4727"},{"id":"A313","pred":"chebi_id","subj":"T313","obj":"http://purl.obolibrary.org/obo/CHEBI_28984"},{"id":"A314","pred":"chebi_id","subj":"T314","obj":"http://purl.obolibrary.org/obo/CHEBI_91150"}],"text":"24 Human, primary microglia (El-Hage et al. 2014)\nHIVSF162 (R5) No • U50,488; U69,593 (KOR agonists)\n• Dynorphin Al-13 ↓ HIV p24 Human, primary microglia (Chao et al. 1996b)\n• HIVJR-FL (R5)\n• gp120 No β-endorphin • ↑ HIV expression\n• ↑ HIV p24 (14-day post infection)\n• gp12"}

{"project":"LitCovid-sentences","denotations":[{"id":"T515","span":{"begin":44,"end":49},"obj":"Sentence"},{"id":"T516","span":{"begin":50,"end":100},"obj":"Sentence"},{"id":"T517","span":{"begin":101,"end":166},"obj":"Sentence"},{"id":"T518","span":{"begin":167,"end":173},"obj":"Sentence"},{"id":"T519","span":{"begin":174,"end":189},"obj":"Sentence"},{"id":"T520","span":{"begin":190,"end":231},"obj":"Sentence"},{"id":"T521","span":{"begin":232,"end":267},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"24 Human, primary microglia (El-Hage et al. 2014)\nHIVSF162 (R5) No • U50,488; U69,593 (KOR agonists)\n• Dynorphin Al-13 ↓ HIV p24 Human, primary microglia (Chao et al. 1996b)\n• HIVJR-FL (R5)\n• gp120 No β-endorphin • ↑ HIV expression\n• ↑ HIV p24 (14-day post infection)\n• gp12"}

{"project":"2_test","denotations":[{"id":"32876803-24732776-62958048","span":{"begin":44,"end":48},"obj":"24732776"}],"text":"24 Human, primary microglia (El-Hage et al. 2014)\nHIVSF162 (R5) No • U50,488; U69,593 (KOR agonists)\n• Dynorphin Al-13 ↓ HIV p24 Human, primary microglia (Chao et al. 1996b)\n• HIVJR-FL (R5)\n• gp120 No β-endorphin • ↑ HIV expression\n• ↑ HIV p24 (14-day post infection)\n• gp12"}